Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evolution of structural rearrangements in prostate cancer intracranial metastases.
Khani F, Hooper WF, Wang X, Chu TR, Shah M, Winterkorn L, Sigouros M, Conteduca V, Pisapia D, Wobker S, Walker S, Graff JN, Robinson B, Mosquera JM, Sboner A, Elemento O, Robine N, Beltran H. Khani F, et al. Among authors: conteduca v. NPJ Precis Oncol. 2023 Sep 13;7(1):91. doi: 10.1038/s41698-023-00435-3. NPJ Precis Oncol. 2023. PMID: 37704749 Free PMC article.
Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study.
Dammacco F, Tucci FA, Lauletta G, Gatti P, De Re V, Conteduca V, Sansonno S, Russi S, Mariggiò MA, Chironna M, Sansonno D. Dammacco F, et al. Among authors: conteduca v. Blood. 2010 Jul 22;116(3):343-53. doi: 10.1182/blood-2009-10-245878. Epub 2010 Mar 22. Blood. 2010. PMID: 20308602 Free article. Clinical Trial.
Circulating tumor cells: utopia or reality?
Conteduca V, Zamarchi R, Rossi E, Condelli V, Troiani L, Aieta M. Conteduca V, et al. Future Oncol. 2013 Sep;9(9):1337-52. doi: 10.2217/fon.13.101. Future Oncol. 2013. PMID: 23980681 Review.
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.
Caroli P, De Giorgi U, Scarpi E, Fantini L, Moretti A, Galassi R, Celli M, Conteduca V, Rossi L, Bianchi E, Paganelli G, Matteucci F. Caroli P, et al. Among authors: conteduca v. Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):348-354. doi: 10.1007/s00259-017-3866-2. Epub 2017 Nov 6. Eur J Nucl Med Mol Imaging. 2018. PMID: 29110067 Clinical Trial.
149 results